Medical Care Technologies Inc. (OTC Pink:MDCE) Strengthens Foundational AI Infrastructure as Company Prepares for Next Development Milestones

Rhea-AI Summary

Medical Care Technologies (OTC Pink: MDCE) announced it has begun a new infrastructure and early system testing phase to scale its AI-driven health analytics platform on November 25, 2025. The company said work targets both a Clinical AI Division (clinical validation track) and a Consumer AI Division (preventive health, emotional wellness, dietary and lifestyle tools).

Preparatory activities listed include architecture optimization, module compatibility testing, data ingestion stress tests, early safety and compliance assessments, and predictive model tuning. Management framed these steps as groundwork for continued development and testing.

MESA, ARIZONA / ACCESS Newswire / November 25, 2025 / Medical Care Technologies Inc. (OTC Pink:MDCE) today confirmed that it has initiated the next stage of infrastructure preparation and early system testing to support the long-term scalability of its AI-driven health analytics platform.

With AI capabilities advancing rapidly, MDCE is focused on creating a flexible, future-proof structure that enables continuous refinement of its technologies. This includes preparing both the Clinical AI Division - which aims to pursue clinical validation-and the Consumer AI Division, which focuses on preventive health insights, emotional wellness tools, dietary tools and lifestyle metrics.

The preparatory phase includes:

• Core architecture optimization

• Module-to-module compatibility testing

• Data ingestion stress tests

• Early safety and compliance assessments

• Predictive analytics model tuning

"These steps position us for stable growth as we move deeper into development and testing," said CEO Marshall Perkins. "Artificial intelligence continues to advance, and our platform is evolving with it-supported by the groundwork we are laying today."

Safe Harbor Statement

This press release contains forward-looking statements based on current expectations. Actual results may differ due to risks and uncertainties. Medical Care Technologies Inc. assumes no obligation to update forward-looking statements except as required by law.

About Medical Care Technologies Inc.

Medical Care Technologies Inc. (OTC Pink: MDCE) is developing a next-generation AI health analytics platform that uses image-based and biometric data to predict, detect signs of chronic disease. Its mission is to create accessible, non-invasive screening tools that empower both clinicians and individuals to identify health risks before they become critical.

Contact:

Investor Relations
Medical Care Technologies Inc.
info@infiniteauctions.com
Website: www.mdcestock.com

SOURCE: Medical Care Technologies Inc. (OTC PINK:MDCE)

View the original press release on ACCESS Newswire

FAQ

What did Medical Care Technologies (MDCE) announce on November 25, 2025?

The company began infrastructure preparation and early system testing to scale its AI health analytics platform, covering clinical and consumer AI divisions.

What specific infrastructure tests is MDCE performing to support its AI platform?

MDCE listed core architecture optimization, module-to-module compatibility testing, data ingestion stress tests, safety and compliance checks, and predictive model tuning.

How will MDCE’s Clinical AI Division be used after the infrastructure phase?

The Clinical AI Division is being prepared to pursue clinical validation of the company's AI-driven health analytics technologies.

What consumer features is MDCE developing in its Consumer AI Division?

The Consumer AI Division focuses on preventive health insights, emotional wellness tools, dietary tools, and lifestyle metrics.

Does the announcement include financial guidance or revenue figures for MDCE?

No; the announcement describes development and testing steps but does not provide financial guidance or revenue figures.